On Wednesday, Ventas, Inc. (NYSE:VTR)’s shares inclined 0.46% to $56.89.
Ventas, Inc. (VTR) said that its Chairman and Chief Executive Officer Debra A. Cafaro has been named by Modern Healthcare Magazine as one of the 100 Most Influential People in Healthcare for 2015. This is the second time that Ms. Cafaro has been coprised of in this list, reflecting her influence and stature in the healthcare industry.
President Barack Obama and U.S. Supreme Court Chief Justice John Roberts are at the top of the ranking, which also comprises Senate Majority Leader Mitch McConnell and the CEOs of leading healthcare providers counting Kaiser Permanente, Ascension, HCA and Advocate Health Care. Ms. Cafaro is the only executive from the real estate industry to be comprised of in the Modern Healthcare ranking, which is compiled annually based on voting from the magazine’s readers
Ventas, Inc. is a publicly owned real estate investment trust. The firm engages in investment, administration, financing, and leasing of properties in the healthcare industry. It invests in the real estate markets of the United States and Canada.
Biogen Inc (NASDAQ:BIIB)’s shares dropped -0.24% to $298.34.
PureTech Health plc (“PureTech” or the “Company”, LSE: PRTC), a science-driven healthcare company seeking to develop disruptive solutions to address unmet medical needs and improve the lives of patients, recently declared that Michael MacLean has been designated to PureTech’s administration team as Chief Financial Officer and Executive Vice President.
Michael MacLean joins PureTech from Iron Mountain Inc. (IRM), the FORTUNE 1000 global storage and information administration company, where he was Chief Financial Officer of its North American business overseeing $2.2bn of annual revenue and about $1bn of EBITDA. Formerly, Mr. MacLean was Senior Vice President, Finance and Chief Accounting Officer at Biogen (BIIB), a global biopharmaceutical company with annual revenues of more than $9bn, during which time he managed many of the finance and accounting functions and was responsible for structuring and managing collaborations and planned acquisitions. He also was an audit partner at global public accounting firms counting KPMG, one of the largest professional services companies in the world where he supported global clients in industries counting pharmaceuticals, medical devices and diagnostics.
Biogen Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurological, autoimmune, and hematologic disorders in the United States and internationally. It provides AVONEX to treat relapsing multiple sclerosis (MS); TYSABRI to treat relapsing forms of MS and Crohn’s disease; PLEGRIDY to treat relapsing MS; TECFIDERA to treat MS; FAMPYRA to improve walking in adult patients with MS; ALPROLIX to treat hemophilia B; ELOCTATE to treat hemophilia A; RITUXAN for treating non-Hodgkin’s lymphoma, rheumatoid arthritis, and chronic lymphocytic leukemia (CLL), in addition to two forms of ANCA-associated vasculitis; GAZYVA for the treatment of patients with formerly untreated CLL; and FUMADERM to treat severe plaque psoriasis in adult patients.
At the end of Wednesday’s trade, Kohl’s Corporation (NYSE:KSS)‘s shares dipped -0.77% to $48.53.
Kohl’s (KSS) anticipates hiring more than 69,000 associates nationwide this holiday season to support seasonal business in stores and growth on Kohls.com.
Kohl’s anticipates hiring an average of 50 associates per store to provide customers with excellent service throughout the holiday season at its 1,166 stores in 49 states. In addition, the company anticipates hiring about 9,500 seasonal positions at distribution and e-commerce fulfillment centers across the country and about 660 seasonal credit operations positions.
Kohl’s is now offering customers the option to buy online at Kohls.com and pick up their order in store at all Kohl’s locations across the country. Seasonal associates will assist in fulfilling those orders, as well as Kohls.com orders designated to ship from stores direct to Kohl’s customers. Seasonal associates in stores also assist with freight processing and customer service on the sales floor and at the point of sale.
Kohl’s Corporation operates department stores in the United States. It offers private label, exclusive, and national brand apparel, footwear, accessories, beauty, and home products to children, men, and women customers.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
